<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib12">
 <label>12</label>
 <element-citation publication-type="journal" id="sref12">
  <person-group person-group-type="author">
   <name>
    <surname>Azijn</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Tirry</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Vingerhoets</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>de Béthune</surname>
    <given-names>M.P.</given-names>
   </name>
   <name>
    <surname>Kraus</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Boven</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Jochmans</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Van Craenenbroeck</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Picchio</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Rimsky</surname>
    <given-names>L.T.</given-names>
   </name>
  </person-group>
  <article-title>TMC278, a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI), active against wild-type and NNRTI-resistant HIV-1</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <volume>54</volume>
  <year>2010</year>
  <fpage>718</fpage>
  <lpage>727</lpage>
  <pub-id pub-id-type="pmid">19933797</pub-id>
 </element-citation>
</ref>
